EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Quercetin suppresses the progression of HBV-associated hepatocellular carcinoma by modulating the EGFR signaling pathway

Zhijuan Wang iD, Jinzhen Huang, Danping Huang, Rui An, Guangdong Tong, Weiqu Yuan, Mianmian Liao, Qiusheng Zhong

PLOS One · 2026

DOI: 10.1371/journal.pone.0350584 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Zhijuan Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Dongguan Key Laboratory of Traditional Chinese Medicine Hepatology, the Affiliated Dongguan Songshan Lake Central Hospital, Guangdong Medical Univers…. Hauptthemen laut MEDLINE: Quercetin, Liver Neoplasms, Carcinoma, Hepatocellular, Signal Transduction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Quercetin, a bioactive flavonoid compound widely present in medicinal and edible plants, has demonstrated therapeutic potential against hepatocellular carcinoma (HCC). However, its specific mechanism in hepatitis B virus-associated hepatocellular carcinoma (HBV-HCC) remains unclear. This study aims to systematically elucidate the efficacy and molecular mechanisms of quercetin against HBV-HCC.

Methods

Integrated in vitro and in vivo experimental models were employed. The inhibitory effects of quercetin on HCC cell viability, proliferation, clonogenicity, and migration were assessed through CCK-8, EdU, colony formation, and scratch assays. Network pharmacology and molecular docking were integrated to identify potential targets of quercetin within HCC. Lentiviral transfection was used to construct HCC cell lines overexpressing HBx and EGFR, with key signaling pathways verified via Western blot. Additionally, a xenograft mouse model was established, and the EGFR inhibitor osimertinib was combined to evaluate quercetin’s therapeutic efficacy and underlying mechanisms in HBV-HCC.

Results

Through an extensive analysis of the target interaction network analysis of quercetin in HCC, this study identified and prioritized 29 potential therapeutic targets, with the EGFR recognized as the principal target molecule. The results of molecular docking experiments indicated that both EGFR and GSK3β exhibited good binding affinity. Subsequent in vitro studies revealed that quercetin substantially suppresses the growth and migration of HBV-HCC cells. It achieves this by dose-dependently suppressing EGFR, thereby attenuating the signaling of the downstream PI3K/AKT/GSK3β axis and concurrently reversing the epithelial-mesenchymal transition (EMT) process. In vivo investigations, complemented by control studies using EGFR inhibitors, further validate that quercetin exerts its anti-tumor effects against HBV-HCC through specific targeting of EGFR and the suppression of the EMT program.

Conclusion

This research validates the therapeutic effectiveness of quercetin in inhibiting HBV-HCC and elucidates the molecular mechanisms responsible for its action. Mechanistically, quercetin inhibits the PI3K/AKT/GSK3β signaling axis by targeting EGFR, thereby reversing the EMT process and ultimately impeding HBV-HCC progression. These critical outcomes provide a novel theoretical foundation for the targeted therapy of HBV-HCC using quercetin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuercetinLiver NeoplasmsCarcinoma, HepatocellularSignal TransductionHepatitis BErbB ReceptorsHumansAnimalsMiceHepatitis B virusMolecular Docking SimulationCell ProliferationCell Line, TumorCell MovementGlycogen Synthase Kinase 3 betaXenograft Model Antitumor AssaysMice, NudeEpithelial-Mesenchymal TransitionDisease ProgressionMale

Substanzen

QuercetinErbB ReceptorsEGFR protein, humanGlycogen Synthase Kinase 3 beta

Autor:innen und Institutionen

  • Dongguan Key Laboratory of Traditional Chinese Medicine Hepatology, the Affiliated Dongguan Songshan Lake Central Hospital, Guangdong Medical University, Dongguan, China (Primary Supporting Institution).
  • Guangdong Pharmaceutical University, No. 280 East Huan Road, University City, Panyu District, Guangdong Province, China.
  • Guangzhou University of Chinese Medicine Shenzhen Hospital (Futian), No. 1, Fuhua Road, Futian District, Shenzhen City, Guangdong Province, China.
  • Department of Acupuncture, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong Province, China.

ORCID-Profile: Zhijuan Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, Z., Huang, J., Huang, D., An, R., Tong, G., Yuan, W., Liao, M., & Zhong, Q. (2026). Quercetin suppresses the progression of HBV-associated hepatocellular carcinoma by modulating the EGFR signaling pathway. PLOS One. https://doi.org/10.1371/journal.pone.0350584

Vancouver

Wang Z, Huang J, Huang D, An R, Tong G, Yuan W, et al. Quercetin suppresses the progression of HBV-associated hepatocellular carcinoma by modulating the EGFR signaling pathway. PLOS One. 2026. doi:10.1371/journal.pone.0350584

BibTeX
@article{Wang2026,
  author = {Wang, Zhijuan and Huang, Jinzhen and Huang, Danping and An, Rui and Tong, Guangdong and Yuan, Weiqu and Liao, Mianmian and Zhong, Qiusheng},
  title = {Quercetin suppresses the progression of HBV-associated hepatocellular carcinoma by modulating the EGFR signaling pathway},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0350584}
}
Kostenlos starten →